DESCRIPTION
A 66-year-old woman presented to the emergency department after being found unconscious in her home. She lived alone and had no contact with the healthcare system for the past 20 years. On presentation, her vital signs included a temperature of 31.2°C (88.2°F), heart rate of 46 bpm and blood pressure of 109/64 mm Hg. On examination, she had thin and brittle hair, loss of the lateral third of her eyebrows, macroglossia and doughy periorbital oedema (figure 1). Laboratory data revealed a thyroid-stimulating hormone of 131.6 mIU/mL. The patient was diagnosed with myxoedema coma. She was started on intravenous hydrocortisone and intravenous levothyroxine. Over the next 3 weeks, the patient regained consciousness, symptoms improved and the myxoedema resolved (figure 2). Four weeks after admission, she was discharged home on oral levothyroxine 125 mg/day and continues to do well on this regimen.
Myxoedema coma, the extreme manifestation of hypothyroidism, is exceedingly rare due to the widespread availability of thyroid-stimulating hormone assay. It is an endocrine emergency associated with a high mortality rate. The hallmark presentation of myxoedema coma includes decreased mental status and hypothermia. Associated features include bradycardia, hypotension and hypoglycaemia. Physical findings in myxoedema coma include the classic myxoedematous face, which is characterised by generalised puffiness, macroglossia, ptosis and periorbital oedema, and coarse, sparse hair, 1 as seen in our patient. The name 'myxoedema coma' is somewhat of a misnomer, as patients frequently present with altered consciousness rather than coma. Learning points ▸ Myxoedema coma may present with the classic myxoedema facies characterised by macroglossia, ptosis and periorbital oedema, however, not all patients exhibit the full list of classic findings, and a coma is not required for diagnosis. ▸ Treatment begins with intravenous levothyroxine and intravenous hydrocortisone until associated adrenal insufficiency is ruled out. ▸ Myxoedema coma has a significant mortality rate but early recognition and clinical diagnosis may save the patient's life.
